Publication Name	World Journal of Hepatology
Manuscript ID	5430
Country	Japan

Received	2013-09-11 08:29
Peer-Review Started	2013-09-11 14:47
To Make the First Decision	2013-10-14 14:07
Return for Revision	2013-10-14 18:08
Revised
Second Decision	2013-11-04 16:22
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2013-11-05 08:32
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-11-11 01:31
Typeset the Manuscript	2013-11-21 14:28
Publish the Manuscript Online	2013-11-26 22:03

ISSN	1948-5182 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Hepatitis B virus reactivation with rituximab-containing regimen
Manuscript Source	Invited Manuscript
All Author List	Yutaka Tsutsumi, Yoshiya Yamamoto, Joji Shimono, Hiroyuki Ohhigashi and Takanori Teshima
Funding Agency and Grant Number
Corresponding Author	Yutaka Tsutsumi, MD, PhD, Department of Hematology, Hakodate Municipal Hospital, Hakodate 1-10-1, Minato-cho, Hakodate 041-8680, Japan. yutsutsu@shore.ocn.ne.jp
Key Words	Rituximab; Hepatitis B virus; Reactivation; Chemotherapy; Lamivudine; Non-Hodgkin's lymphoma
Core Tip	The deleterious effects of hepatitis B virus (HBV) reactivation in rituximab-containing chemotherapy regimens have been reported and the effect of lamivudine treatment in the prevention of HBV reactivation is also well documented. Once reactivated, HBV may lead to death due to hepatitis. In this review, we discuss the factors of preventive lamivudine treatment (especially in the course of HBV antibody), including to whom and for how long the drug should be given, based on case studies and reports that span rituximab’s debut in 2002 on the Japanese market to June 2013.
Publish Date	2013-11-26 22:03
Citation	Tsutsumi Y, Yamamoto Y, Shimono J, Ohhigashi H, Teshima T. Hepatitis B virus reactivation with rituximab-containing regimen. World J Hepatol 2013; 5(11): 612-620
URL	http://www.wjgnet.com/1948-5182/full/v5/i11/612.htm
DOI	http://dx.doi.org/10.4254/wjh.v5.i11.612

Full Article (PDF)	WJH-5-612.pdf
Manuscript File	5430-Review.doc
Answering Reviewers	5430-Answering Reviewers.pdf
Copyright License Agreement	5430-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	5430-Language Certificate.pdf
Peer-review Report	5430-Peer Review(s).pdf
Scientific Editor Work List	5430-Scientific editor work list.doc